Bone-Regulating MicroRNAs and Resistance Exercise: A Mini-Review

Abstract

MicroRNAs (miRNA) are a class of short noncoding RNA that play important roles in controlling gene expression. Many miRNAs have been identified as being important regulators of bone cell function, thus affecting the bone remodeling processes. In addition to being expressed in specific tissues and exerting intracellular effects, miRNAs can enter the blood where they can be taken up by other tissues. These circulating miRNAs (c-miRNA) also have clinical significance as biomarkers of musculoskeletal diseases as they are tissue-specific, are stable and easily detectable, and require minimally invasive procedures. This mini-review discusses miRNAs with regulatory roles in bone metabolism and c-miRNA responses to acute bouts of resistance exercise. MiRNA responses (e.g., upregulation/downregulation of expression) vary depending on the resistance exercise protocol characteristics and the age of the participants. There are gaps in the literature that need to be addressed as most of the resistance exercise studies focused on miRNAs that regulate skeletal muscle in male participants.

1. Introduction

A rapidly emerging topic in osteoporosis research is the use of microRNAs (miRNA, miR) as biomarkers of bone status since they are key regulatory players in bone remodeling [1,2,3]. MiRNAs are a class of short (21–22 nucleotides (nt) in length) noncoding RNA that play important roles in controlling gene expression; specifically as negative regulators of gene expression [4]. A large number of miRNAs are important regulators of bone cell function, with some miRNAs promoting or suppressing bone formation and others promoting or suppressing bone resorption [1,3]. In addition to being expressed in specific tissues and having intracellular effects, miRNAs can enter into the blood in response to various stimuli including tissue injury and mechanical stress. These circulating miRNAs (c-miRNA) have clinical significance as biomarkers of musculoskeletal diseases as they are tissue-specific, are stable and easily detectable, and require minimally invasive procedures (e.g., venous blood sample) [2]. Recent findings documenting dysregulated miRNAs in the serum of osteoporosis patients [5,6,7], have generated much excitement as they support the use of circulating miRNAs as biomarkers for bone loss and osteoporosis [2] as well as highlight their therapeutic potential for bone disease [8] (Figure 1).

Besides their basic tissue physiology effects, c-miRNAs may have important regulatory functions for physiological adaptations to exercise training, and may be useful as biomarkers of exercise responses. These topics are of growing interest to exercise scientists (refer to [9,10] for in depth reviews). High intensity resistance exercise has been shown to have positive effects on bone mineral density [11] and bone turnover markers [12]. Muscle contraction can stimulate osteogenesis by producing a strain stimulus and through the release of miRNAs. Much of the literature on miRNA responses to resistance exercise has focused on miRNAs that regulate skeletal muscle; however, miRNAs also may play a regulatory role in bone adaptations to resistance exercise. This mini-review will discuss miRNA physiology, the regulatory role of miRNAs in bone metabolism and osteoporosis, and miRNA responses to mechanical loading and resistance exercise.

2. MiRNA Physiology

MiRNA genes are initially transcribed by RNA polymerase II from the introns of messenger RNA (mRNA) in the nucleus to form primary miRNA, which is folded and contains a hairpin structure [13]. The enzyme complex containing Drosha and DiGeorge syndrome critical region 8 (DGCR8) edit the primary miRNA to pre-miRNA. Pre-miRNA is transported to the cytoplasm via Exportin-5. Once in the cytoplasm, the pre-miRNA is bound to an Argonaut protein. The enzyme, Dicer, cleaves the hairpin structure of the pre-miRNA to form a miRNA duplex. One strand of the duplex disassociates and is degraded. The remaining strand, now a mature miRNA, bound to the Argonaute protein forms the RNA-Induced Silencing Complex (RISC). The RISC complex negatively regulates protein translation post-transcription by selectively binding nt 2–9 to the 3′ untranslated region of mRNA. Binding to mRNA either interferes with protein translation or leads to the degradation of the mRNA. Multiple RNAs are targetable by a single MiRNA, and greater than 60% of human genes are affected by them [14].

3. Regulatory Role of MiRNAs in Bone Metabolism

Previous research has indicated that miRNAs are involved in all stages of osteogenesis by regulating differentiation, proliferation, apoptosis, and activity of different bone cells: osteocytes, osteoblasts, osteoclasts, and bone marrow stem cells (

Table 1. Select MiRNAs with Bone Cell Regulatory Effects.

MiRNA	Target Gene	Pathway/Enzyme	Biological Effect
miR-21-5p	SMAD7 PDCD4	BMP, TGF-β c-Fos	Promote OB differentiation Promote OC differentiation
miR-23a-3p	RUNX2 SMAD3	TGF-β	Suppress OB differentiation Suppress OB differentiation
miR-100-5p	BMPR2 SMAD1	BMP BMP	Suppress OB differentiation Suppress OB differentiation
miR-125b-5p	BMPR OSX	BMP RUNX2	Suppress OB differentiation Suppress OB differentiation
miR-126-3p	MMP13	Matrix Degeneration	Suppress OC differentiation
miR-133a-3p	RUNX2 CXCL11	Rank	Suppress OB differentiation Promote OC differentiation
miR-148a-3p	KDM6B MAFB	TGF-β Rank	Suppress OB differentiation Promote OC differentiation

Modified from [3,5]. OB—osteoblast; OC—osteoclast; SMAD7—Small Mothers Against ecapentaplegic 7; BMP—Bone Morphogenetic Protein; TGF-β—Transforming Growth Factor-Beta; DCD4—Programmed Cell Death Protein 4; RUNX2—Runt-related Transcription Factor 2; SMAD3—Small Mothers Against Decapentaplegic 3; BMPR2—BMP receptor type II; BMPR—BMP receptor; SMAD1—Small Mothers Against Decapentaplegic 1; OSX—Osterix; MMP13—Matrix Metalloproteinase 13; CXCL11—C-X-C Motif Chemokine Ligand 11; KDM6B—Lysine Demethylase 6B; AFB—V-maf Musculoaponeurotic Fibrosarcoma Oncogene Homolog B.

) [3]. Bone-regulating miRNAs are those expressed in osteoblast lineage cells for regulation of bone formation by either direct repression of inhibitors of osteoblast differentiation or by their response to osteogenic signals, such as BMP (Bone Morphogenetic Protein), to promote osteogenesis. A growing number of MiRNAs have been identified to regulate osteoblastogenesis and bone formation by targeting inhibitors of osteogenesis or osteogenic factors [3]. Some MiRNAs stimulate osteoblastogenesis, such as miR-15b, -20a, whereas some MiRNAs inhibit osteoblastogenesis, such as miR-23a-3p, -100-5p, and -133a-3p. This occurs primarily through regulating BMP-RUNX2 (Runt-Related Transcription Factor 2) and Wnt (Wingless-Type MMTV Integration Site Family) signaling pathways. For example, miR-100-5p directly targets BMPR2 (BMP receptor type II) and inhibits osteoblastogenesis. Research on the role of miRNAs in osteocytes is in its early stages, however, miRNAs are expressed in osteocytes and have been shown to regulate osteocyte differentiation [15]. MiRNAs also regulate the differentiation and proliferation of chondrocytes; miR-125b-5p is reported to stimulate the differentiation of chondrocytes in mouse by repressing an inhibitor of chondrogenesis [16].

MiR-21-5p, a widely studied miRNA, is ubiquitously expressed and has regulatory roles in both osteoblast and osteoclast activities [2,3,17,18]. MiR-21-5p promotes bone formation by inhibiting SMAD7 (Small Mothers Against Decapentaplegic 7), a protein that inhibits osteoblast differentiation via the BMP and TGF-β (Transforming Growth Factor-Beta) pathways. MiR-21-5p also promotes osteoclastogenesis via a positive feedback loop involving c-Fos, a factor that promotes osteoclast formation, and PDCD4 (Programmed Cell Death Protein 4), a protein that acts to inhibit osteoclast formation through c-Fos inhibition [17,19]. In the positive feedback loop, c-Fos upregulates miR-21-5p expression, which then suppresses PDCD4 expression, thereby reducing its inhibitory effect on c-Fos (Figure 2A) [20]. Estrogen deficiency in postmenopausal women upregulates miR-21-5p, which acts to suppress the transcription of FASL (Fas Ligand) [21]. As a result, osteoclast apoptosis is inhibited, promoting bone resorption activity. Another miRNA, miR-23a-3p targets the RUNX2 and SMAD3 (Small Mothers Against Decapentaplegic 3) pathways, inhibiting osteoblast differentiation [22], thus high levels of miR-23a-3p inhibit bone formation, and the net imbalance favors bone resorption (Figure 2B). We recently reported a positive relationship between miR-23a-3p and the bone resorption marker, TRAP5b (Transforming Growth Factor-Beta), in postmenopausal women that may be attributed to their regulatory roles on bone resorption since high serum TRAP5b concentrations indicate a greater number of osteoclasts, which favors bone resorption [23].

4. MiRNAs and Osteoporosis

MiRNAs regulate osteogenesis and are associated with bone diseases such as osteoporosis (refer to review [3]) and may serve as biomarkers for osteoporosis. Wang et al. [24] measured miRNAs in circulating monocytes in 20 postmenopausal women. The cohort was dichotomized into high and low BMD groups and compared for miRNA expression levels. Of the miRNAs assessed, miR-133a-3p was expressed significantly higher in the low BMD group. The target for miR-133a-3p in bone is RUNX2, and higher levels in tissue would have a negative impact on bone formation.

Seeliger et al. [5] analyzed circulating and bone tissue miRNAs in osteoporotic (n = 10) and non-osteoporotic (n = 10) patients with hip fractures. In the two sample types, 5 miRNAs (miR-21-5p, -23a-3p, -24, -100-5p, -125b-5p) were expressed higher in osteoporotic patients. MiR-21-5p may affect bone through inhibition of PDCD4, which allows for osteoclast survival. MiR-23a-3p and -24 are implicated in inhibition of RUNX2 for osteocyte formation. MiR-100-5p may negatively affect bone formation by inhibiting BMPR2, thus halting the growth of pre-osteoblasts into mature osteoblasts. MiR-125b-5p may also affect formation by inhibiting mesenchymal stem cell differentiation towards an osteoblastic lineage. Weilner at al. [25] also assessed miRNAs in osteoporotic fracture patients. Serum samples from 37 postmenopausal women (>65 years) were collected, 19 of which had recent fractures due to osteoporosis. Samples were taken within two weeks of surgery. Differentially expressed miRNAs included three upregulated (miR-10a-5p, 10b-5p, -22-3p) and three downregulated (miR-133b -328-3p, let-7g-5p). A validation cohort was also used to validate the differentially expressed miRNAs. It was found that only miR-22-3p, -328-3p and let-7g-5p reached significance. In the case of miR-22-3p, the first study saw significant upregulation while the validation cohort had significant downregulation. Of note, there were no differences between fracture patients and controls for miR-21-5p. Panach et al. [6] assessed c-miRNA in eight osteoporotic fracture patients (mean 80 years) compared to five controls with osteoarthritis. They found that miR-122-5p, -125-5p, -21-5p were significantly upregulated in the fracture patients. MiR-21-5p was highly correlated with the bone resorption marker, CTX-I (C-telopeptide of Type I collagen cross-links) and several miRNAs (miR-21-5p, -125b-5p, -122-5p, -210) were positively correlated with bone formation markers (osteocalcin, bone-specific alkaline phosphatase). Although miR-21-5p can have an osteogenic effect, it appears that in fracture patients, miR-21-5p serves to improve osteoclastic function to a greater degree. Kelch et al. [7] found that miR-21-5p expression was higher in both serum and in bone tissue of male and female patients with osteoporotic fractures versus normal controls, suggesting a role for miR-21-5p in bone loss. Both cultured osteoclast and osteoblast cells from bone tissue of osteoporotic fracture patients showed upregulation of miR-21-5p expression.

In a recent study, we assessed circulating miRNAs in 75 postmenopausal women aged 60–85 years based on osteoporosis and sarcopenia status [23]. We measured miR-1-3p, -21-5p, -23a-3p, -24-3p, -100-5p, -125b-5p, -133a-3p, -206, miRNAs associated with targets in muscle and bone, and the bone resorption markers, CTX-I and TRAP5b. There were no significant differences in c-miRNA expression between osteoporotic and non-osteoporotic and sarcopenic and non-sarcopenic participants; however, there were potentially biologically relevant differences in fold changes of miR-21-5p and miR-23a-3p, which were upregulated in osteoporotic women, and in miR-125b-5p which was downregulated in the osteoporotic group.

5. MiRNAs and Mechanical Loading

In vitro studies have shown that mechanical loading changes miRNA expression, which in turn, may be important regulatory mechanisms for the exercise-induced adaptations in bone metabolism [26]. Cell line studies provide evidence that miR-21-5p is sensitive to mechanical loading as it was upregulated in human periodontal stem cells by a stretch load [27] but downregulated in MC3T3-E1 cells by fluid shear stress promoting osteogenic differentiation [28]. In mice, miR-21-5p deficiency inhibited osteoclast function and bone resorption leading to increased trabecular bone accrual [17].

5.1. Skeletal Muscle MiRNAs

MiRNAs are involved in the regulation of hypertrophy and other muscular adaptations. Table 2 shows a summary of skeletal muscle and serum/plasma miRNA responses to acute bouts of resistance exercise studies in humans. Drummond et al. [29] compared miRNA expression in skeletal muscle following acute resistance exercise and essential amino acids ingestion in young (mean 29 years) and older (mean 70 years) men. MiR-1 expression was downregulated in young but not in older men following the exercise stimulus, indicating that aging results in a dysregulated miRNA response after an anabolic stimulus. Rivas et al. [30] also compared the skeletal muscle miRNA responses to acute resistance exercise in younger and older men. Similar to Drummond et al. [29], they found that alterations in miRNA expression were age-dependent, as a large number of miRNA were downregulated and 1 miRNA (miR-486-5p) upregulated in young men, whereas there were no miRNA changes in skeletal muscle of older men after the resistance exercise bout.

Telles et al. [31] compared skeletal muscle miRNA responses in young men to three types of acute exercise protocols; resistance exercise, high-intensity interval exercise, and both resistance and high-intensity interval exercise performed concurrently. They used a targeted approach for the miRNA analysis, selecting 8 miRNAs with known regulatory roles in skeletal muscle development. Their main findings were that 7/8 miRNAs were upregulated up to 8 h after acute exercise, with 6 miRNA (miR-1-3p, -133a-3p, -133b-3p, -181a-3p, -378a-5p, -486) showing similar responses for all 3 exercise protocols, and 2 miRNAs (miR-23a-3p, -206) having greater changes in expression for the resistance exercise compared to the high-intensity interval exercise protocol.

5.2. Circulating MiRNAs

Sawada et al. [32] assessed c-miRNA responses in 12 young men (~29 years) performing bench press and bilateral leg press. Participants performed five sets of ten repetitions at 70% 1 RM and had serum samples taken before, immediately after, 60 min, 1 day, and 3 days after exercise. There was no significant change for miR-133 nor miR-21-5p post-exercise, only downregulation of miR-146a and miR-221 three days post-exercise and upregulation of miR-149a 24 h post-exercise. MiR-21-5p had a weak positive correlation with the catecholamines, epinephrine and norepinephrine, and testosterone and IGF-1 were weakly positively correlated with miR-222.

C-miRNA expression changes to acute exercise may be attenuated by aging. Margolis et al. [33] reported different patterns of c-miRNA expression in response to acute high intensity resistance exercise with aging as c-miRNA profiles were downregulated in older men but upregulated in younger men. Three miRNAs, miR-19b-3p, -206, -486, significantly predicted skeletal muscle aging. Of the 10 c-miRNA that were differentially expressed in young versus older men, 6 (miR-19a-3p, -19b-3p, -20a-5p, -26b-5p, -143-3p, -195-5p) were associated with inhibition of the PI3K-Akt pathway, which would increase activation of the Akt-mTOR pathway and increase cellular protein synthesis.

D’Souza et al. [34] observed the effects of an acute resistance exercise bout on the expression of miRNAs in skeletal muscle tissue and plasma in 9 healthy young males. Subjects performed 6 sets of 8–10 repetitions for leg press and 8 sets of 8–10 repetitions for knee extension. Samples were collected pre, 2 h, and 4 h post-exercise. From skeletal muscle biopsy, miR-133a-3p, -206a increased 2 h post- and miR-146a-5p increased 4 h post-exercise. MiR-23a-3p decreased 2 h post- and further decreased 4 h post-exercise. Of the c-miRNA, miR-133a-3p and -149-5p were elevated from baseline, while miR-1, -208a, and -499 were undetected. Only miR-133a-3p had increased expression in both plasma and skeletal muscle tissue and may serve as a marker for muscle damage.

Cui et al. [35] assessed the time-course of c-miRNA expression from three different resistance exercise protocols in young men. The three protocols consisted of five exercises: bench press, squat, pulldown, overhead press, and standing dumbbell curl and were performed at different volumes and intensities. The strength-endurance (SE) group performed three sets of 16–20 repetitions at 40% 1RM with one-min rest intervals. The muscular hypertrophy (MH) group performed three sets of 12 repetitions at 70% of 1RM with two-min rest intervals. The maximum strength (MS) group performed four sets of six repetitions at 90% of 1RM with three-min rest intervals. For the SE group, miR-532 fold changes increased 1 h post-exercise and remained elevated 24 h later while miR-208b decreased immediately post-exercise and remained depressed. The MH group showed decreased expression for miR-21, and -133a, immediately post-exercise, and miR-221 1 h post-exercise. MiR133b was upregulated 24 h post-exercise, while miR-181a and miR-206 were upregulated 1 h post-exercise, then returned to baseline 24 h later. For the MS group, miR-133a significantly decreased expression immediately post- and returned to baseline 1 h post-exercise. MiR-133b increased expression from immediately post- to 1 h post-exercise. The authors concluded that miR-133a may be a potential biomarker of physiological muscle strain for resistance exercise at very high intensities (e.g., 90% 1RM). The changes seen in miR-21 may be indicative of an initial pro-inflammatory response, followed by an anti-inflammatory response.

Evaluating c-miRNA responses to exercise may provide insight into the potential benefits of exercise in ameliorating the negative effects of aging on musculoskeletal health. There is a paucity of data in the literature on c-miRNA responses to acute exercise in postmenopausal women. We recently studied the effects of acute resistance exercise and whole-body vibration on expression of selected c-miRNAs in physically active postmenopausal women aged 65–76 years [36]. This randomized crossover design study compared c-miRNA responses to a bout of resistance exercise (RE) (3 sets 10 reps 70% 1 repetition maximum (1RM), 5 exercises) and a bout of whole-body vibration (WBV) (5 sets 1 min bouts 20 Hz 3.38 mm peak to peak displacement. We targeted 4 c-miRNAs (miR-21-5p, -23a-3p, -133a-3p, -148a-3p) that have been shown in the literature to regulate bone metabolism. The main finding was that c-miR-21-5p expression was downregulated from 60 min post to 24 h post-exercise for only the whole-body vibration protocol. Absolute changes in the bone resorption marker (TRAP5b) were negatively correlated with c-miR-21-5p fold changes for both whole-body vibration and resistance exercise modalities and there were significant moderate to strong negative correlations between baseline c-miRNAs and bone status variables. Based on our findings, whole-body vibration induces a sufficient mechanical stimulus for altering c-miR-21-5p expression. The lack of c-miRNA responses to the high intensity resistance exercise protocol may be related to the older age of the postmenopausal women, since previous studies [29,30,33] have reported age-associated differences in miRNA responses to a resistance exercise stimulus.

Table 2. MiRNA Responses to Acute Resistance Exercise (RE) Protocols.

Study	RE Protocol	Target Population	Sample	Upregulation	MiRNA Responses Downregulation	No Change
Drummond et al. [29]	Leg extension 8 sets 10 reps 70% 1RM	Young men (n = 6) Older men (n = 6)	Muscle		Young only miR-1	Young miR-133a miR-206 All in older men
Sawada et al. [32]	Bench press Leg Press 5 sets 10 reps 70% 1RM	Young men (n = 12)	Serum	miR-149	miR-146a miR-221
Rivas et al. [30]	Bilateral Knee Extension 3 sets 10 reps 80% 1RM	Young men (n = 8) Older men (n = 8)	Muscle	Young only miR-486-5p	Young only miR-23b-3p -24-3p, -26a-3p -27a-3p, -27b-3p -29c-3p, -30a-5p -30d-5p, -95-3p -126-3p, -133a -133b, -140-3p -181a-3p, -378a-5p	All in older men
Margolis et al. [33]	Bilateral Knee Extension, Leg Press 3 sets 10 reps 80% 1RM	Young men (n = 9) Older men (n = 9)	Serum	Young miR-221-3p -222-3p -206	Older miR-31-5p -124-3p, -211-5p -375
D’Souza et al. [34]	Leg press 6 sets 8–10 reps 80% 1RM Knee extension 8 sets 8–10 reps 80% 1RM	Young men (n = 9)	Muscle Plasma	Muscle miR-23a-3p, -133a-3p, -146a-5p, -206a, -378b -486-5p Plasma miR-133a-3p -149-5p
Cui et al. [35]	Bench press, Squat, Pull-down, Overhead Press, Dumbbell Curl Hypertrophy 3 sets 12 reps 70% 1RM Strength 4 sets 6 reps 90% 1RM Strength Endurance	Young men (n = 45)	Plasma	Hypertrophy miR-133b -181a, -206 Strength miR-133b Strength-Endurance miR-532	Hypertrophy miR-21 -133a, -221 Strength miR-133a Strength-Endurance miR-208b
	3 sets 16–20 reps 40% 1RM
Telles et al. [31]	Leg press Knee extension 4 sets 8–12 RM High-intensity interval exercise (HIIE) Concurrent resistance and high-intensity interval exercise (CON)	Young men (n = 9)	Muscle	all 3 protocols miR-1-3p -133a-3p -133b-3p -181a-3p -486, RE > HIIE, CON miR-23a-3p,-206		all 3 protocols miR-378a-5p
Buchanan [36]	Leg press Shoulder press Lat pulldown Knee extension Hip adduction 3 sets 10 reps 70–75% 1RM Whole-body vibration (WBV) 5–1 min sets 3.38 mm peak-to-peak displacement 2.7 g	Postmenopausal women (n = 10)	Serum		WBV only miR-21-5p	all for RE

miR—MicroRNA; RM—Repetition Maximum.

Table 2. MiRNA Responses to Acute Resistance Exercise (RE) Protocols.

Study	RE Protocol	Target Population	Sample	Upregulation	MiRNA Responses Downregulation	No Change
Drummond et al. [29]	Leg extension 8 sets 10 reps 70% 1RM	Young men (n = 6) Older men (n = 6)	Muscle		Young only miR-1	Young miR-133a miR-206 All in older men
Sawada et al. [32]	Bench press Leg Press 5 sets 10 reps 70% 1RM	Young men (n = 12)	Serum	miR-149	miR-146a miR-221
Rivas et al. [30]	Bilateral Knee Extension 3 sets 10 reps 80% 1RM	Young men (n = 8) Older men (n = 8)	Muscle	Young only miR-486-5p	Young only miR-23b-3p -24-3p, -26a-3p -27a-3p, -27b-3p -29c-3p, -30a-5p -30d-5p, -95-3p -126-3p, -133a -133b, -140-3p -181a-3p, -378a-5p	All in older men
Margolis et al. [33]	Bilateral Knee Extension, Leg Press 3 sets 10 reps 80% 1RM	Young men (n = 9) Older men (n = 9)	Serum	Young miR-221-3p -222-3p -206	Older miR-31-5p -124-3p, -211-5p -375
D’Souza et al. [34]	Leg press 6 sets 8–10 reps 80% 1RM Knee extension 8 sets 8–10 reps 80% 1RM	Young men (n = 9)	Muscle Plasma	Muscle miR-23a-3p, -133a-3p, -146a-5p, -206a, -378b -486-5p Plasma miR-133a-3p -149-5p
Cui et al. [35]	Bench press, Squat, Pull-down, Overhead Press, Dumbbell Curl Hypertrophy 3 sets 12 reps 70% 1RM Strength 4 sets 6 reps 90% 1RM Strength Endurance	Young men (n = 45)	Plasma	Hypertrophy miR-133b -181a, -206 Strength miR-133b Strength-Endurance miR-532	Hypertrophy miR-21 -133a, -221 Strength miR-133a Strength-Endurance miR-208b
	3 sets 16–20 reps 40% 1RM
Telles et al. [31]	Leg press Knee extension 4 sets 8–12 RM High-intensity interval exercise (HIIE) Concurrent resistance and high-intensity interval exercise (CON)	Young men (n = 9)	Muscle	all 3 protocols miR-1-3p -133a-3p -133b-3p -181a-3p -486, RE > HIIE, CON miR-23a-3p,-206		all 3 protocols miR-378a-5p
Buchanan [36]	Leg press Shoulder press Lat pulldown Knee extension Hip adduction 3 sets 10 reps 70–75% 1RM Whole-body vibration (WBV) 5–1 min sets 3.38 mm peak-to-peak displacement 2.7 g	Postmenopausal women (n = 10)	Serum		WBV only miR-21-5p	all for RE

miR—MicroRNA; RM—Repetition Maximum.

6. Conclusions

The assessment of miRNAs, particularly in the blood, is a rapidly growing area of research that may increase the understanding of the regulatory roles of miRNAs in disease pathology and in physiological responses of tissues to exercise. Figure 3 depicts a theoretical model for miRNA and bone formation responses to the mechanical strain induced by skeletal muscle contraction during resistance exercise. To date, resistance exercise studies have focused on miRNAs regulating muscle tissue, not bone tissue, and most of the studies have been conducted in men. The available data suggest that miRNAs are differentially expressed in young versus older participants in response to resistance exercise. There are gaps in the literature that need to be addressed, specifically more information is needed on bone-specific miRNA responses to resistance exercise, and more studies need to be conducted in women, especially postmenopausal women who are at greater risk for osteoporosis.